High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.2M
$2,153,155
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
APLS
S
Apellis Pharmaceuticals, Inc.
Dunlop A. Sinclair
• Director
10b5-1 SellΔOwn -89.0%
2025-10-10
$737,536
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Director
10b5-1 SellΔOwn -89.0%
|
2025-10-10 | $737,536 | S | Form 4 |
|
APLS
S
Apellis Pharmaceuticals, Inc.
Dunlop A. Sinclair
• Director
10b5-1 SellΔOwn -47.8%
2025-09-30
$702,057
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Director
10b5-1 SellΔOwn -47.8%
|
2025-09-30 | $702,057 | S | Form 4 |
|
APLS
S
Apellis Pharmaceuticals, Inc.
Dunlop A. Sinclair
• Director
10b5-1 SellΔOwn -31.1%
2025-09-19
$713,561
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Director
10b5-1 SellΔOwn -31.1%
|
2025-09-19 | $713,561 | S | Form 4 |